Stock overview
Cytomx Therapeutics Inc.
Explore the company, reported ownership, price history, and available source evidence.
CYTOMX THERAPEUTICS INC (CTMX) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $1.88
- · CTMX
- Tracked holders
- 2 funds
- Latest available 13F per fund
CTMX · USD
Price
Close · Nov 18, 2026
- Range low
- $1.88
- Range high
- $6.75
- Observations
- 252
- Session date
- Nov 18, 2026
Nov 18, 2025–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Baker Bros. Advisors largest tracked holder Q3 2026 · filed Nov 16, 2026 · SEC filing | — | $13,534,247 | 0.06% |
| Tudor Investment Corp position history Q3 2026 · filed Nov 16, 2026 · SEC filing | −87% 26'Q3 | $508,833 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market